Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-5,696.22
% of Total Estimate Gain
-10.60%

Allspring Factor Enhanced U.S. Large Cap Equity Portfolio's Alnylam Pharmaceuticals Inc Holding Summary

As of 2023-11-30, Allspring Factor Enhanced U.S. Large Cap Equity Portfolio held - shares of Alnylam Pharmaceuticals Inc(ALNY), totaling N/A. This investment constitutes 0% of their stock portfolio, and Allspring Factor Enhanced U.S. Large Cap Equity Portfolio now holds 0% of the outstanding Alnylam Pharmaceuticals Inc(ALNY) stock.

The initial trade took place in 2023Q3. And since then Allspring Factor Enhanced U.S. Large Cap Equity Portfolio has made 1 purchases of ALNY, at an average price of $193.24, for a total of 278.00 shares. In addition, there have been 1 sales at an average price of $172.75 for 278.00 shares. Based on historical transaction data and ALNY's current price of $323.01, Allspring Factor Enhanced U.S. Large Cap Equity Portfolio's estimated gain on his ALNY holdings is $-5,696.22, reflecting a -10.60% gain to date.

Allspring Factor Enhanced U.S. Large Cap Equity Portfolio ALNY ($323.01) Holding Chart

Allspring Factor Enhanced U.S. Large Cap Equity Portfolio ALNY ($323.01) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1